A human monoclonal macroglobulin with specificity for alpha(2----8)- linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA

doi:10.1084/jem.164.2.642

This Article

	Full Text (PDF, 841K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kabat, E. A.
	Articles by Yang, Y. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kabat, E. A.
	Articles by Yang, Y. H.


Social Bookmarking

	What's this?

ARTICLES

A human monoclonal macroglobulin with specificity for alpha(2----8)- linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA

EA Kabat, KG Nickerson, J Liao, L Grossbard, EF Osserman, E Glickman, L Chess, JB Robbins, R Schneerson and YH Yang

We have described an IgM antibody from a patient with macroglobulinemia specifically reacting with poly-alpha(2----8)N-acetyl neuraminic acid (NeuNAc) the capsular polysaccharide of two important human pathogens, group B meningococcus and E. coli K1. This antibody has a narrowly defined specificity in its interactions with polysaccharides, being unable to bind poly-alpha(2----9)NeuNAc or alternating poly-alpha(2---- 8)alpha(2----9)NeuNAc. However, it shows interesting crossreactivity with seemingly unrelated polynucleotides and denatured DNA, supporting the hypothesis that charged groups with a given spacing may determine the specificity of antigen-antibody interactions on otherwise dissimilar molecular structures. Despite the crossreactivity with denatured DNA and polynucleotides, the antibody does not appear to have adverse effects in the patient. The antibody protects newborn rats against E. coli K1 infection, as well as the standard horse antiserum H46, and one would expect it to prove useful in humans as an adjunct to antibiotic therapy in infections with group B meningococcus and E. coli K1. We have attempted to clone the antibody-producing cells from peripheral blood, and have shown that the relevant cells are present and can be cultured.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Azurmendi, H. F., Vionnet, J., Wrightson, L., Trinh, L. B., Shiloach, J., Freedberg, D. I. (2007). Extracellular structure of polysialic acid explored by on cell solution NMR. Proc. Natl. Acad. Sci. USA 104: 11557-11561 [Abstract] [Full Text]
Sun, J., Takahashi, N., Kakinuma, H., Nishi, Y. (2001). Molecular Evolution of Catalytic Antibodies in Autoimmune Mice. J. Immunol. 167: 5775-5785 [Abstract] [Full Text]
Sun, Y., Park, M. K., Kim, J., Diamond, B., Solomon, A., Nahm, M. H. (1999). Repertoire of Human Antibodies against the Polysaccharide Capsule of Streptococcus pneumoniae Serotype 6B. Infect. Immun. 67: 1172-1179 [Abstract] [Full Text]
Tchernychev, B., Cabilly, S., Wilchek, M. (1997). The epitopes for natural polyreactive antibodies are rich in�proline. Proc. Natl. Acad. Sci. USA 94: 6335-6339 [Abstract] [Full Text]
Sato, C., Kitajima, K., Inoue, S., Seki, T., Inoue, Y. (1995). Characterization of the Antigenic Specificity of Four Different Anti-(alpha2[IMAGE]8-Linked Polysialic Acid) Antibodies Using Lipid-conjugated Oligo/Polysialic Acids. J. Biol. Chem. 270: 18923-18928 [Abstract] [Full Text]
Ravirajan, C.T., Kalsi, J., Winska Wiloch, H., Barakat, S., Tuaillon, N., Irvine, W., Cockayne, A., Harris, A., Williams, D.G., Williams, W., Axford, J., Muller, S., Isenberg, D.A. (1992). Antigen-Binding Diversity of Human Hybridoma Autoantibodies Derived from Splenocytes of Patients with SLE. Lupus 1: 157-165 [Abstract]